67 research outputs found
Demographic and clinical characteristics of the patient cohort.
<p>Demographic and clinical characteristics of the patient cohort.</p
Comparison of IIEF-5 scores between patients with and without each UPOINT domain.
<p>Mean IIEF-5 scores were compared between patients with and without each urinary (U), psychosocial (P), organ specific (O), infection (I), neurological/systemic (N), and tenderness (T) UPOINT domain. Significant difference was seen in psychosocial, organ specific, and tenderness domains between no and yes (*P<0.05).</p
Comparison of NIH-CPSI symptom scores between patients with and without each UPOINTS domain.
<p>Mean total NIH-CPSI symptom scores were compared between patients with and without each urinary (U), psychosocial (P), organ specific (O), infection (I), neurological/systemic (N), tenderness (T), and sexual dysfunction (S) UPOINTS domain, respectively. Significant difference was seen in each domain between no and yes (*P<0.05).</p
Complications by modified<i>C</i>lavien classification.
*<p>Some cases experienced one or more complications.</p
Demographic and clinical preoperative characteristics.
<p>Demographic and clinical preoperative characteristics.</p
Determinants of kidney stones (KS) and calcium oxalate stones (COS) for all 197 subjects, respectively.
<p>OR = odds ratio; CI = confidence intervals.</p
Demographic, clinical, and biochemical data.
<p>SD, standard deviation; COS, calcium oxalate stones; NCOS, non-calcium oxalate stones; AAM, age at menopause; TSM, time since menopause ; BMI, body mass index; WDC, water drink consumption; WET, working environment temperature; HTN, hypertension; DM, diabetes mellitus; RA, rural area of life; T, testosterone; E2, estradiol. P-values were determined using the Wilcoxon rank sum test, or the chi-square tests between all patients and controls subjects. Post-hoc analyses were performed for comparison of variables between the following cohorts: COS, NCOS, controls, COS versus NCOS, COS versus controls, and NCOS versus controls, with p-values<0.05 considered significant."* "indicate group is significantly from the control."#" indicate group is significantly from the COS.</p
Spearman’s correlation using estradiol (E2) and testosterone (T) as dependent variables in all 197 subjects.
<p>Spearman’s correlation using estradiol (E2) and testosterone (T) as dependent variables in all 197 subjects.</p
Characteristics of the study population (n =197) per tertile of estradiol.
<p><sup>a, b, c</sup> Different superscripts indicate significant differences among groups, p<0.05.</p
- …